Xcout IntelJUNTEN BIO
Junten Bio Co. Ltd. is a Japanese pharmaceutical and biotechnology corporation headquartered in Tokyo, specializing in the research and development of cell and regenerative medicine.
Subscribe to see JUNTEN BIO’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
JUNTEN BIO at a glance
JUNTEN BIO is a biotechnology company headquartered in Japan. Its most recent funding round, Seed, closed in June 2019. Xcout tracks 6 named people at JUNTEN BIO, including 河南 雅成 (代表取締役).
JUNTEN BIO leadership
- 河南 雅成代表取締役
- 西崎 政男代表取締役
- 児玉 俊太郎取締役
- 奥村 康取締役
- 松尾 健介取締役
- 茂田井 純一監査役
JUNTEN BIO funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | Undisclosed | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
JUNTEN BIO competitors
A few of JUNTEN BIO's closest competitors — see the full list of competitors and alternatives →
Cell Research Corporation is a biotechnology company specializing in umbilical cord lining stem cell technology and banking. The company provides products, services, and contract research related to stem cell applications for wound healing, regenerative medicine, and cosmeceuticals.
Restore Vision Inc. is a Japanese startup headquartered in Tokyo that aims to develop visual restoration gene therapies.
Rejuvenate Bio, Inc. is a biotechnology company founded in 2019 and headquartered in San Diego, United States, specializing in innovative gene therapy applications.
Medipost Co., Ltd. is a South Korean biotechnology company developing and commercializing stem-cell-based regenerative medicines, including treatments derived from human umbilical cord blood mesenchymal stem cells. It also operates a cord-blood banking business serving expectant parents and families.
NutrigeneAI Biotech Limited is an iPSC cell therapy platform operating in Hong Kong. The company focuses on biotechnology research and development, maintaining pipeline therapies and regional office operations.
Yubo International Biotech Limited, operating through its various subsidiaries, primarily dedicates its efforts to the research, development, and practical application of endometrial stem cells. Beyond this core focus, the company also provides a diverse range of products, including solutions for respiratory health, skincare and hair care formulations, nutritious beverages, and personal care items tailored for both men and women. Furthermore, it delivers specialized stem cell services, such as cellular analysis and comprehensive health management consulting, all offered under the VIVCELL brand. The company's headquarters are located in Beijing, China.
Get JUNTEN BIO's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on JUNTEN BIO in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access